Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Curcumin Market Capitalizes on Popularity of Turmeric as a Wonder Herb to Attract R&D Investments

Frost & Sullivan
Posted on: 31 Jul 17

SANTA CLARA, Calif., July 31, 2017 /PRNewswire/ -- The increasing awareness of the value of curcumin in the formulation of, nutraceuticals, dietary supplements, herbals, cosmetics, functional foods and beverages, and other applications is creating a plethora of opportunities for extract and ingredient manufacturers. There is particular focus on curcumin R&D, as manufacturers are looking to differentiate themselves by offering novel curcumin ingredients using technologies that standardize its concentration to 95 percent and increase its bioavailability. Furthermore, investors are showing greater interest in the product due to large volumes of existing clinical data detailing the structure-function relationships of the active curcuminoids. There also have been many human clinical trials to establish its efficacy and safety in specific applications, such as prevention and supportive treatment of digestive disorders, arthritis, cancers and cardiovascular diseases.

Global Curcumin Market, Forecast to 2023 is part of Frost & Sullivan's Future of Agriculture & Nutrition Growth Partnership Subscription. This study will help clients understand consumer preferences that are evolving due to changing lifestyles and health awareness. North America is the biggest market for curcumin, while Europe leads market growth.

Click here for complimentary access to more information on this analysis and to register for a Growth Strategy Dialogue, a free interactive briefing with Frost & Sullivan's thought leaders.

"Curcumin R&D is mainly aimed at obtaining extracts with higher solubility, bio-absorption, bioavailability and other value-added properties that widen its application scope," said Frost & Sullivan Visionary Science Principal Analyst Raghu Tantry. "Manufacturers have already succeeded in increasing its absorption in the gastrointestinal tracts post oral intake by humans. Its demonstrated utility in disease prevention and pain relief in inflammatory disorders such as rheumatism and osteoarthritis, as well as its anti-cancer properties, greatly enhance its profile and draw investments."

Turmeric, the raw material source of curcumin, is a widely used ingredient in traditional food and medicinal recipes in the Indian sub-continent and Southeast Asia. However, consumers are still unaware of all the differences between turmeric and curcumin in terms of content and therapeutic or health benefits. Due to this, ingredient suppliers struggle to position their products optimally. They need to invest in educating customers across the value chain by employing trained technical support and customer service staff.

"The specialty natural ingredients industry is very active in developing commercially relevant curcumin extract products and conducting research that best serves formulators and consumers," noted Tantry. "Suppliers with testing and development capabilities have a competitive edge in the market, as they are considered ideal solution providers to formulators and finished product manufacturers. Their ability to customize curcumin ingredients, aid in trial and pilot batch preparation, and smoothly escalate to commercial batch manufacture and global distribution will earn them significant partnership opportunities in diverse application areas."

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

Global Curcumin Market, Forecast to 2023
K149-39

Contact:
Jaylon Brinkley
Corporate Communications – North America
P: (210) 247.2481
F: (210) 348.1003
E: jaylon.brinkley@frost.com

http://www.frost.com

For more information:
www.frost.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 31/07/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.